Dr Reddy’s, Zydus, Cipla, Sun can sustain low-double digit EPS growth over medium term: Bino Pathiparampil
Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.
Indiatimes20h
Tata Consumer Share Price Returns
Tata Consumer Products Ltd. key Products/Revenue Segments include Tea, Other Operating Revenue, Royalty Income for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has ...